Amgen Earnings, Revenue beat In Q1

  • Investing.com
  • Stock Market News
Amgen Earnings, Revenue beat In Q1
Credit: © Reuters.

Investing.com - Amgen (NASDAQ: AMGN ) reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Amgen announced earnings per share of $4.25 on revenue of $6.24B. Analysts polled by Investing.com anticipated EPS of $4.12 on revenue of $6.11B.

Amgen shares are down 4% from the beginning of the year and are trading at $239.61 , down-from-52-week-high.They are outperforming the S&P 500 which is down 12.22% from the start of the year.

Amgen shares lost 3.69% in after-hours trade the report.

Amgen follows other major Healthcare sector earnings this month

Amgen's report follows an earnings beat by UnitedHealth on Thursday, April 14, 2022, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.

J&J had beat expectations on Tuesday, April 19, 2022 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100